These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15136323)

  • 1. CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis.
    Cantón A; Martinez-Cáceres EM; Hernández C; Espejo C; García-Arumí J; Simó R
    Arch Ophthalmol; 2004 May; 122(5):743-9. PubMed ID: 15136323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis.
    Kojima K; Maruyama K; Inaba T; Nagata K; Yasuhara T; Yoneda K; Sugita S; Mochizuki M; Kinoshita S
    Ophthalmology; 2012 Nov; 119(11):2386-92. PubMed ID: 22809758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
    Li X; Jiang Y; Ye C; Li C
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
    Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
    Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
    Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
    Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
    Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cryocoagulation in therapy of proliferative diabetic retinopathy].
    Pauleikhoff D; Engineer B; Wessing A
    Klin Monbl Augenheilkd; 1997 Mar; 210(3):147-52. PubMed ID: 9206746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitrectomy for complications of diabetic retinopathy.
    Smiddy WE
    Int Ophthalmol Clin; 1998; 38(2):155-67. PubMed ID: 9604743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of membrane dissection and en bloc excision on the outcome of vitreous surgery in proliferative diabetic retinopathy].
    Li XX; Jiang YR; Yin H; Zhao MW
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):439-42. PubMed ID: 15454056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of cryocoagulation and posterior vitrectomy in proliferative diabetic retinopathy complicated by hemorrhage into the vitreous body].
    Milen'kaia TM
    Oftalmol Zh; 1988; (2):76-9. PubMed ID: 2456502
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
    Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
    Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group.
    Arch Ophthalmol; 1985 Nov; 103(11):1644-52. PubMed ID: 2865943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
    Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
    Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
    Lee DY; Jeong HS; Sohn HJ; Nam DH
    Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
    Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The morphologic structure of vitreous hemorrhage and posterior vitreous detachment].
    Weng N; Wei W; Zhu X
    Zhonghua Yan Ke Za Zhi; 2001 Nov; 37(6):425-7. PubMed ID: 11840748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Limitation of photocoagulation in diabetic neoproliferative retinopathy as a function of the patients' age].
    Vallat M; Reynaud X; Salomon JL; Lhomme C; Duprat F; Mathon C
    Bull Soc Ophtalmol Fr; 1990; 90(8-9):761-4. PubMed ID: 2257649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.